CAMSPay receives in-principle authorization from RBI to operate as a Payment Aggregator

To widen the scope and coverage of CAMSPay in offering a robust and inclusive digital payment stack to customers 

 

CAMSPay, a panoptic payment platform specializing in solving BFSI sector’s payment challenges has received in-principle authorization from Reserve Bank of India to operate as a Payment Aggregator (PA).

Part of Computer Age Management Services Limited (CAMS), India’s largest registrar and transfer agent of mutual funds (a SEBI regulated entity), CAMSPay has been an integral payments partner supporting Mutual Fund investors, Insurance policyholders and Loan borrowers for over a decade in enabling them move from paper-based mandate process to offering digital payment solutions. As a specialized payments solutions provider to the BFSI segment, the in-principal authorization from RBI to operate as a Payment Aggregator will widen the scope and coverage of CAMSPay.

“CAMSPay provides a wide range of payment options including Digital Payments, Payment Gateway, Cards, UPI, and Net Banking. The in-principle authorization from RBI to operate as a Payment Aggregator is a key milestone towards further strengthening our offerings  in the BFSI segment. We reaffirm our commitment to making payments more seamless and secure to all stakeholders ” said Mr. Ravi Kiran, Head of New Businesses for CAMS. 

Mr. Vasanth Jeyapaul, CEO, CAMSPay said, “We are thrilled to receive the in-principle authorisation to operate as a Payment Aggregator to create a much more robust and inclusive digital payment stack for the chosen merchant segments that we operate in, delivering a variety of acceptance options. The license will help us further fortify our  offerings in the payments arena”.

Mutual Fund Investors use CAMSPay for their SIP and bullet investments, Insurance Policy holders for paying their policy premia and loan borrowers for repaying their loans.  With a comprehensive suite of  payment options, CAMSPay is well-known for its strong commitment to compliance and security.  CAMSPay works with over fifty financial institutions which include mutual funds, insurance companies, and NBFCs across India. As the first to provide UPI Autopay service to the Mutual Funds sector, CAMSPay continues to lead the market with its innovative payment solutions. 

  • Related Posts

    Mumbai Students Win Big at Robotics Championship in Chicago, Headed to World Finals

    In an exceptional achievement, Mumbai-based high school robotics team Sigma 9692 has won the prestigious Engineering Inspiration Award at the FIRST Robotics Midwestern Regional Championship held in Chicago, USA. With…

    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    The National Bio Entrepreneurship Competition (NBEC), India’s largest and most prestigious bio-entrepreneurship platform, was officially launched on 3rd April 2025 at Startup Maha Kumbh, marking the opening of applications for…

    You Missed

    Mumbai Students Win Big at Robotics Championship in Chicago, Headed to World Finals

    • By editor
    • April 5, 2025
    • 50 views
    Mumbai Students Win Big at Robotics Championship in Chicago, Headed to World Finals

    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    • By editor
    • April 5, 2025
    • 47 views
    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    Moody’s Ratings Upgrades Muthoot Finance Ratings to ‘Ba1’ with ‘Stable’ Outlook

    • By editor
    • April 4, 2025
    • 44 views
    Moody’s Ratings Upgrades Muthoot Finance Ratings to ‘Ba1’ with ‘Stable’ Outlook

    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future

    • By editor
    • April 4, 2025
    • 59 views
    The National Bio Entrepreneurship Competition Unveiled at Startup MahaKumbh: A Platform to Shape India’s Biotech Future